Tecvayli

teclistamab-cqyv

Approval

ApplicationBLA 761291
Approval dateOct 25, 2022
Approval year2022
SponsorJanssen Biotech

FDA-approved use

To treat relapsed or refractory multiple myeloma among adults who have received at least four specific lines of therapy

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Tecvayli: